Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Diabetes Mellitus Article
This is a selection made from among articles on Drug Treatment Diabetes Mellitus. For a permanent link to this article, or to bookmark it for future reading, click here.
Effective Alcohol and Drug Treatment
from:by Morgan Hamilton
Alcohol and drug treatment has evolved quite a bit of past few decades. The first forms of alcohol and drug treatment were actually quite primitive compared to what's available today. In the dark ages it was thought that addictions were caused by demonic possession, which had many different prescribed ‘cures’ ranging from blood letting to being burned at the stake. In the 19th and early 20th century, alcohol and drug treatment had made some strides towards improvements as opposed to when addictions were then considered forms of insanity and the treatments of choice involved straight jackets, padded rooms, and electric shocks. Could you imagine? You have to wonder what they were thinking?What we consider today as modern alcohol and drug treatment didn’t really start until the second half of the 20th century. This was no doubt one of the well-known and often repeated ’12 step’ program designed by Alcoholics Anonymous. Doctors and practitioners slowly came to realize that effective alcohol and drug treatment was in fact a possibility. Some of the first forms of alcohol and drug treatment centers formed in this time were not much more than centers where the 12 step program could be taught. The treatments were actually more psychological than anything else. Even well into the 1980’s handing someone a ‘big book’ (the Alcoholics Anonymous guide) and telling them to go to 90 meetings in 90 days was a common and acceptable form of alcohol and drug treatment. We have made great strides from then in our understanding of what does and what does not work as far as drug and alcohol treatment is concerned. Please don't misunderstand me, the 12 step program can be effective for some individuals. One often really wonderful things about it is that it is for a show anyone who needs to help can take advantage of, there are no economic barriers. There is no reason to pay exorbitant fees for alcohol and drug treatment only to get a copy of the big book and a list of nearby meetings. Finding listings for meetings in your area is as simple as calling on the Internet or looking through a phone book. This doesn’t mean that alcohol and drug abuse treatment isn’t necessary. The treatment should be seen as a supplement to two other programs and not relied upon as a stand-alone solution. When you do decide to seek alcohol and drug abuse treatment be sure that you select one that is known for providing services beyond just 12 step model functions. I myself am a counselor and a recovering addict from my experience I can say with some confidence that the most effective way to help yourself in recovery is to try out many different forms of alcohol and drug treatment, don't limit yourself because we are all different. If you follow this advice you are sure to find at least some methods that will be effective for you.
Morgan Hamilton offers his findings and insights regarding health and medicine. You can get interesting information here at Alcohol and Drug Treatment
Drug Treatment Diabetes Mellitus Specific links
Drug Treatment Diabetes Mellitus News
Lilly Optimistic on Type-2 Diabetes Drug for Black Patients - Fox Business
Lilly Optimistic on Type-2 Diabetes Drug for Black Patients Fox Business The study proved the efficacy and safety profile of the drug, known experimentally as linagliptin. The drug is intended to be used with diet and exercise to lower blood sugar in adults with type 2 diabetes mellitus. The treatment, unlike some of its ... |
New Phase 3 data for Tradjenta® (linagliptin) tablets in black or African ... - Sacramento Bee
New Phase 3 data for Tradjenta® (linagliptin) tablets in black or African ... Sacramento Bee TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. TRADJENTA is a DPP-4 inhibitor that does not require dose adjustments regardless of declining renal function or hepatic ... |
New Phase 3 data for Tradjenta® (linagliptin) tablets in black or African ... - MarketWatch (press release)
New Phase 3 data for Tradjenta® (linagliptin) tablets in black or African ... MarketWatch (press release) TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. TRADJENTA is a DPP-4 inhibitor that does not require dose adjustments regardless of declining renal function or hepatic ... |
Dulaglutide passes BP hurdle, but heart-rate increase observed - TheHeart.Org
Dulaglutide passes BP hurdle, but heart-rate increase observed TheHeart.Org New York, NY - Early data from a small study testing a new glucagonlike peptide-1 (GLP-1) agonist showed the drug significantly reduced blood pressure in a group of patients with type 2 diabetes mellitus. Both doses tested in the phase 2 study met the ... |
FDA Approves Levemir® for Expanded Use in Children Two to Five Years of Age ... - MarketWatch (press release)
FDA Approves Levemir® for Expanded Use in Children Two to Five Years of Age ... MarketWatch (press release) Levemir® is a man-made long-acting insulin that is used to control high blood sugar in adults and children with diabetes mellitus. It is not recommended to use Levemir® to treat diabetic ketoacidosis. Do not take Levemir® if you are allergic to any of ... |
EMA accepts Takeda's submission of diabetes drug alogliptin - The Pharma Letter
EMA accepts Takeda's submission of diabetes drug alogliptin The Pharma Letter Takeda previously postponed its MAA for alogliptin (SYR-322) and the fixed dose combination of alogliptin and pioglitazone (SYR-322-4833), originally planned for mid-2009, as it is initiating a long-term trial for the type 2 diabetes drugs. |
Novartis drug pasireotide LAR shows superior efficacy compared to SandostatinR ... - Reuters
Novartis drug pasireotide LAR shows superior efficacy compared to SandostatinR ... Reuters Caution should be used in patients with insulinomas; patients with diabetes mellitus. Thyroid function should be monitored if receiving prolonged treatment with octreotide. Patients receiving Sandostatin LAR should receive periodic examination of the ... Phase III study results show Novartis drug pasireotide LAR superior to ... |
Latuda(R) (lurasidone HCl) Label Updated With Expanded Dosing Range Providing ... - MarketWatch (press release)
Latuda(R) (lurasidone HCl) Label Updated With Expanded Dosing Range Providing ... MarketWatch (press release) MARLBOROUGH, Mass., May 05, 2012 (BUSINESS WIRE) -- Sunovion Pharmaceuticals Inc. today announced that the US Food and Drug Administration (FDA) has approved an expanded dose range for LATUDA in the treatment of adult patients with schizophrenia. Latuda® (lurasidone HCl) Label Updated With Expanded Dosing Range Providing ... |
New Study Shows Patients Can Effectively be Switched to Latuda(R) (lurasidone ... - MarketWatch (press release)
New Study Shows Patients Can Effectively be Switched to Latuda(R) (lurasidone ... MarketWatch (press release) If signs and symptoms appear in a patient on LATUDA, drug discontinuation should be considered. Hyperglycemia and Diabetes Mellitus: Hyperglycemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported ... |
Pfizer: Alzheimer's Drugs Will Carry Stock To New Highs In 2013 - Seeking Alpha
Pfizer: Alzheimer's Drugs Will Carry Stock To New Highs In 2013 Seeking Alpha Pfizer has a number of diabetes treatments in Phase I and Phase II trials, most of which aim to treat Diabetes Mellitus-Type 2. Competitor Sanofi (SNY) already has a strong presence with the diabetes audience; 10% of Sanofi's total sales are dependent ... |